Navigation Links
Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events
Date:5/6/2008

Pharmacogenetic Findings May Lead to Individualized Treatment for

Schizophrenia

WASHINGTON, MAY 6 /PRNewswire-FirstCall/ -- Data presented today on Vanda Pharmaceuticals Inc.'s (Nasdaq: VNDA) investigational drug candidate, iloperidone, included its 4-week, short-term Phase III trial, as well as a pooled analysis of three long-term, 52-week trials, studying the efficacy and safety of iloperidone. Iloperidone is a 5HT2/D2 antagonist ("atypical") antipsychotic currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia. Additional data were presented identifying genetic markers that may help predict response to iloperidone, which Vanda believes could lead to unique, individualized treatment for schizophrenia. These data were presented today at the 161st American Psychiatric Association (APA) Annual Meeting in Washington, D.C.

"The data from the clinical trials studying the efficacy and safety of iloperidone suggest that iloperidone could be a useful long-term treatment option for people with schizophrenia," said Peter Weiden, M.D., Director of the Psychosis Program of the Department of Psychiatry at the University of Illinois at Chicago and one of the leading experts on adverse events of antipsychotic medications.

The data presented are part of the New Drug Application (NDA) submitted and currently under review by the FDA and demonstrate that iloperidone is effective in the short-term treatment of schizophrenia and that iloperidone is non-inferior to haloperidol in long-term maintenance measured as time to relapse over 52 weeks. In these trials, iloperidone showed short- and long- term safety with respect to movement disorders and metabolic e
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society
2. New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
3. Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
4. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
5. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Data Presented at AAN Support Potential for Adjunctive use of Intravenous Lacosamide as Short-Term Replacement for Oral Treatment in Partial Epilepsy
7. Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome
8. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
9. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
10. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
11. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... EVERETT, Washington , 5. März ... globale Marktführer für Qualitätssicherung im Bereich ... europäischen Kongress für Radiologie, dem European ... Wien , Österreich, einen ... Logo - http://photos.prnewswire.com/prnh/20150304/179432LOGO ...
(Date:3/4/2015)... 4, 2015 China Biologic Products, Inc. (NASDAQ: ... integrated plasma-based biopharmaceutical company in China, today announced its ... 2014. Fourth Quarter 2014 Financial Highlights ... of 2014 increased by 36.2%, or 36.8% excluding the ... million from $42.6 million in the same quarter of ...
(Date:3/4/2015)... 4, 2015 Alimera Sciences, Inc. (NASDAQ: ... that specializes in the research, development and commercialization ... for the fourth quarter and year ended December ... a pivotal year for Alimera Sciences, most notably ... September for the treatment of diabetic macular edema," ...
Breaking Medicine Technology:Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 5China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 6China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 8China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 9China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 10China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 11China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 12China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 13China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 14China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 15China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 16China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 17China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 18China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 19China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 20China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 21China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 22Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 2Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 3Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 4Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 5Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 6Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 7Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 8Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 9Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 10Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 11Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 12Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 13
... person age 65 and older falls every 2.3 seconds in the ... are the leading cause of fatal injury in this age ... and hospital admissions for trauma.  The growing ranks of Americans 65 ... 89 million by 2050 - have inspired a new technology solution ...
... Spine, LLC, a medical device company focused on developing unique ... disease, today announced a 97% sales increase for 2010 versus ... of 2010 versus the prior-year period.  The company also reports ... RSB Spine Chief Executive Officer John A. ...
Cached Medicine Technology:SecuraTrac Reveals Revolutionary Safety Solution Based on GPS & Cellular Technology at CES 2011 2SecuraTrac Reveals Revolutionary Safety Solution Based on GPS & Cellular Technology at CES 2011 3
(Date:3/5/2015)... March 05, 2015 Affirmed Housing is ... Cielo Carmel on March 4 at 10AM. The ... Sherri Lightner, Council president, City of San Diego; ... Atherton, Senior Vice President, Southern California Community Development, Bank ... CEO, San Diego Housing Commission. , Designed ...
(Date:3/5/2015)... March 05, 2015 Hoggan ... dynamometers, ergoFET physical therapy, ergonomic force gauges, ... for ergonomics, engineering, and research applications, introduced ... Dynamometer, available at http://www.HogganHealth.net . The ... offer healthcare professionals a handgrip muscle strength ...
(Date:3/5/2015)... 2015 Medical professionals suggest the physician ... a crisis that is worsening. The demand for doctors ... stay on top of the physician shortage, health care ... meet face-to-face with physicians and advanced practitioners throughout the ... Fair series. , Physician openings take an average of ...
(Date:3/4/2015)... Las Vegas, NV (PRWEB) March 04, 2015 ... good as the fight that is the main event. For ... announced and that fight will be for the UFC Featherweight ... against the brash, often out-spoken native of Ireland, Conor “Notorious” ... the MGM Grand Garden Arena in Las Vegas, NV. , ...
(Date:3/4/2015)... March 04, 2015 The federal litigation ... the statin drug caused patients to develop Type 2 ... Court, District of South Carolina. According to court documents, ... March 26, 2015 at 10:00 a.m. In advance of ... a Joint Status report to the Court by March ...
Breaking Medicine News(10 mins):Health News:SD City Council President Sherri Lightner and Affirmed Housing Break Ground on Affordable Homes in Carmel Valley 2Health News:New Handgrip Strength Tester Receives Rave Reviews At Physical Therapy Conference 2Health News:Physician Shortage Crisis Worsening 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3
... the 89th General Session & Exhibition of the International ... 40th Annual Meeting of the American Association for Dental ... Association for Dental Research, lead researcher F. Cheni will ... "Biodegradable Tooth-binding Micelles Inhibit Streptococcus mutans ( ...
... -- Girls in early adolescence who form friendships with boys ... a new research. The study included 400 female and ... interviewed annually over seven years about their friendship network and ... girls tend to limit their friendships to same-sex peers. But ...
... The oldest segment of Japan,s population will likely be the ... subsequent tsunami, based on data from previous catastrophic events. Approximately ... above. "Japan,s population with the highest proportion of ... of where the world as a whole is headed," said ...
... News) -- Scientists who,ve uncovered the chemistry of mosquito sex ... such as West Nile virus and dengue fever. The ... the male sperm of Aedes aegypti mosquitoes -- ... alter female mosquitoes, tendencies to feed, produce eggs and mate. ...
... passage of the Family Smoking Prevention and Tobacco Control ... (FDA) has met the ambitious implementation deadlines set forth ... congressional briefing hosted by the American Association for Cancer ... FDA Center for Tobacco Products, reviewed the many important ...
... is delivering on its commitment to help the world,s ... an affordable, reliable, and stable treatment for malaria that ... and children in Africa. The Honourable Gary Goodyear, Minister ... Brad Trost, Member of Parliament for SaskatoonHumboldt, announced the ...
Cached Medicine News:Health News:Biodegradable tooth-binding micelles inhibit Streptococcus mutans biofilm growth 2Health News:Teen Girls Who Befriend Boys at Higher Risk for Substance Abuse 2Health News:Japanese tsunami underscores need for elder disaster preparedness 2Health News:Center director says FDA hitting milestones in tobacco law 2Health News:Government of Canada announces results in fight to save women and children with malaria 2
... revolutionary product will provide you with ... of electroretinogram, visual evoked potential, or ... will allow you to perform ERGs ... double flash, photopic negative response, and ...
... The LABOTECH is an ... fully automating immunoenzymatic microplate techniques. ... system adaptable to many manufacturers' ... alternative to traditional R.I.A. and ...
The Rapidpoint 400/405 instrument is a point-of-care blood gas analyzer that's fast, easy to operate and reliable....
... diagnostic accuracy for appropriate treatment options , ... used to inject fluid into the intervertebral ... will measure the pressure of the fluid ... The physician can control the pressure of ...
Medicine Products: